LMRI earnings: real EPS beat/miss history, analyst consensus Strong Buy, P/E -29.41. Updated 2026-07-23.
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Research Hub
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 11.49 USD (+1.86%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -29.41, market cap 1.03B. This hub links to the full technical, earnings and options research available for LMRI.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 11.49 USD (+1.86%) |
| 52-week range | 8.62 USD – 13 USD |
| Trend regime | Range |
| 14-day RSI | 49 (Neutral) |
| Trailing P/E | -29.41 |
| Market cap | 1.03B |
| Dividend yield | 0.00% |
Available research for LMRI
Covered Call on LMRI: how it works, illustrative setup around the real 11.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LMRI: how it works, illustrative setup around the real 11.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LMRI: how it works, illustrative setup around the real 11.49 USD price, max profit/loss, breakeven and when to use it. Educational.
LMRI technical analysis: range, last 11.49 USD, RSI 49, 52w range 8.62 USD–13 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is LMRI in?
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is LMRI in an uptrend or downtrend?
As of 2026-09-11, LMRI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LMRI's trailing P/E ratio?
LMRI's trailing P/E is -29.41, with a market cap of 1.03B. See the earnings research page for full valuation detail.